MMP9 and cystic fibrosis: In fact, CF patients receiving azithromycin have higher MMP-9 levels, as well as alveolar macrophage polarization toward the M2 subtype, thus promoting clinical benefits through a faster ECM turnover (Table 1) [87,88,89,90].